Cargando…

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis

POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: OBJECTIVE: This case series describes our experience of using isavuconazole (ISVCZ), along with TDM, after the failure of treatment with Amphotericin B (AmB) and Posaconazole (PCZ) due to the better PK PD properties of ISVCZ. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soman, Rajeev, Chakraborty, Sourabh, Joe, Geethu, Purandare, Bharat, Joshi, Rasika, Patwardhan, Sampada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541475/ http://dx.doi.org/10.1093/mmy/myac072.P173

Ejemplares similares

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
por: Soman, Rajeev, et al.
Publicado: (2022)

P168 Metastatic mo ld infections after COVID-19: the mo ld time -bomb
por: Soman, Rajeev, et al.
Publicado: (2022)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients
por: DiPippo, Adam J, et al.
Publicado: (2018)

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
por: Ilharco, Marta, et al.
Publicado: (2019)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
por: Keller, Filip, et al.
Publicado: (2023)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Ruan, Lan-hong, et al.
Publicado: (2021)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019)

Amphotericin-b-liposomal/isavuconazole: Lack of efficacy: case report
Publicado: (2021)

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales
por: Ortalli, Gaia, et al.
Publicado: (2023)

P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds
por: Dalvi, Mousami, et al.
Publicado: (2022)

Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
por: Rodrigues, Célia F., et al.
Publicado: (2018)

Amphotericin-B-liposomal/posaconazole: Mixed transaminitis: case report
Publicado: (2021)

Amphotericin B liposomal/posaconazole: Lack of efficacy: case report
Publicado: (2022)

Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis
por: Shafiq, Muhammad, et al.
Publicado: (2018)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus
por: Mahomed, Sharana, et al.
Publicado: (2015)

Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
por: Prayag, Parikshit Shirish, et al.
Publicado: (2023)

S17.3 PK/PD in the treatment of hospital-acquired pneumonia
Publicado: (2005)

P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series
por: Chakraborty, Sourabh, et al.
Publicado: (2022)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)

Amphotericin-B-liposomal/isavuconazole/voriconazole: Lack of efficacy: 6 case report
Publicado: (2022)

Human immunodeficiency virus and the ophthalmologist
por: Soman, Rajeev, et al.
Publicado: (2008)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: Yuan, F., et al.
Publicado: (2021)

A Novel Cryptococcal Meningitis Therapy: The Combination of Amphotericin B and Posaconazole Promotes the Distribution of Amphotericin B in the Brain Tissue
por: Yang, Ming, et al.
Publicado: (2020)

Transcriptional response of Fusarium oxysporum and Neocosmospora solani challenged with amphotericin B or posaconazole
por: Castillo-Castañeda, A., et al.
Publicado: (2020)

Gastric Mucormycosis in a Renal Transplant Patient Treated with Isavuconazole Monotherapy
por: Gani, Imran, et al.
Publicado: (2019)

Successful Treatment of Bilateral Renal Mucormycosis With Isavuconazole: A Case Report
por: Najjar, Yaseen, et al.
Publicado: (2023)

Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
por: Li, Julius, et al.
Publicado: (2015)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK
por: Bagshaw, Emma, et al.
Publicado: (2018)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis
por: Kang, Seung Hun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_anoiom85aidm0jd3brm4tk3aq6